Category Archives: Research and Development

Can unprecedented success in COVID vaccine development boost prospects for an HIV vaccine?

By on .

By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN 702, or Uhambo, was halted for lack of efficacy. Researchers and advocates had high hopes for Uhambo, building as it did on the RV144 trial, which provided the first […]